![]() | Only 14 pages are availabe for public view |
Abstract The study was observational (cross sectional study),conducted in the Neuropsychiatry Department and the center of Neuropsychiatry and Neurosurgery, Tanta University Hospitals from December 2020 to December 2021. The study included epileptic children aged from 3 to 18 years and they were divided into two groups: group I drug-resistant group (DRG): This group included 30 children presented with drug-resistant epilepsy.group II control group (CG):This group included 30 patients with controlled primary epilepsy who achieved sustained seizure freedom on medication matched with the patient group regarding age and sex. |